Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into dozens of batches of the drug that were recalled in November. The Food and Drug Administration said Ranbaxy won’t resume manufacturing generic Lipitor, or atorvastatin, until it determines the problem’s cause and fixes it.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help